BMC Medical Co. Ltd. A (301367) — Cash Flow Reinvestment Rate

Latest as of December 2025: 6.50x

BMC Medical Co. Ltd. A (301367) has a Cash Flow Reinvestment Rate of 6.50x as of December 2025, reinvesting CN¥846.58 Million (capex CN¥32.22 Million plus investments CN¥814.36 Million) from operating cash flow of CN¥130.16 Million. Explore BMC Medical Co. Ltd. A (301367) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

6.50x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥846.58 Million
Capex + Investments

Operating Cash Flow

CN¥130.16 Million
CNY

Capital Expenditures

CN¥32.22 Million
CNY

BMC Medical Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for BMC Medical Co. Ltd. A across 6 annual periods. Also explore 301367 total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BMC Medical Co. Ltd. A (2020–2025)

Year-by-year capital reinvestment analysis for BMC Medical Co. Ltd. A. For live market cap and broader valuation context, see 301367 market cap.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 6.50x CN¥846.58 Million CN¥130.16 Million CN¥32.22 Million ▲ +76.3%
2024 3.69x CN¥568.33 Million CN¥154.08 Million CN¥15.93 Million ▲ +71.0%
2023 2.16x CN¥326.03 Million CN¥151.11 Million CN¥24.12 Million ▼ -57.4%
2022 5.06x CN¥1.90 Billion CN¥375.21 Million CN¥23.75 Million ▲ +185.9%
2021 1.77x CN¥184.90 Million CN¥104.40 Million CN¥10.03 Million ▲ +475.7%
2020 0.31x CN¥82.26 Million CN¥267.41 Million CN¥15.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow